The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Open accessAbstract
The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer, but new platinum agents have been very slow to enter the clinic. Recently, however, there has been a surge of activity, based on a great deal of mechanistic information, aimed at developing nonclassical platinum complexes that operate via mechanisms of action distinct from those of the approved drugs. The use of nanodelivery devices has also grown, and many different strategies have been explored to incorporate platinum warheads into nanomedicine constructs. In this Review, we discuss these efforts to create the next generation of platinum anticancer drugs. The introduction provides the reader with a brief overview of the use, development, and mechanism of action of the approved platinum drugs to provide the context in which more recent research has flourished. We then describe approaches that explore nonclassical platinum(II) complexes with trans geometry or with a monofunctional coordination mode, polynuclear platinum(II) compounds, platinum(IV) prodrugs, dual-threat agents, and photoactivatable platinum(IV) complexes. Nanoparticles designed to deliver platinum(IV) complexes will also be discussed, including carbon nanotubes, carbon nanoparticles, gold nanoparticles, quantum dots, upconversion nanoparticles, and polymeric micelles. Additional nanoformulations, including supramolecular self-assembled structures, proteins, peptides, metal-organic frameworks, and coordination polymers, will then be described. Finally, the significant clinical progress made by nanoparticle formulations of platinum(II) agents will be reviewed. We anticipate that such a synthesis of disparate research efforts will not only help to generate new drug development ideas and strategies, but also will reflect our optimism that the next generation of approved platinum cancer drugs is about to arrive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Electrophoretic Analysis and Purification of Fluorescent Single-Walled Carbon Nanotube Fragments
Xu, X., Ray, R., Gu, Y., Ploehn, H. J., Gearheart, L., Raker, K., & Scrivens, W. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja040082h · Cited by 5,323
Quantum-Sized Carbon Dots for Bright and Colorful Photoluminescence
Sun, Y.-P., Zhou, B., Lin, Y., Wang, W., Fernando, K. A. S., Pathak, P., Meziani, M. J., Harruff, B. A., Wang, X., Wang, H., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062677d · Cited by 5,114
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Self-citationHighly Photoluminescent Carbon Dots for Multicolor Patterning, Sensors, and Bioimaging
Zhu, S., Meng, Q., Wang, L., Zhang, J., Song, Y., Jin, H., Zhang, K., Sun, H., Wang, H., & Yang, B. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300519 · Cited by 3,720
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Cook, T. R., Zheng, Y.-R., & Stang, P. J. (2013) · Chemical Reviews · doi:10.1021/cr3002824 · Cited by 2,950
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Self-citationJain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
Scott, A. M., Wolchok, J. D., & Old, L. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3236 · Cited by 2,160
Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy
Robinson, J. T., Tabakman, S. M., Liang, Y., Wang, H., Sanchez Casalongue, H., Vinh, D., & Dai, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2010175 · Cited by 2,099
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Sahu, S., Behera, B., Maiti, T. K., & Mohapatra, S. (2012) · Chemical Communications · doi:10.1039/c2cc33796g · Cited by 1,803
Fluorescent Carbon Nanoparticles Derived from Candle Soot
Liu, H., Ye, T., & Mao, C. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701271 · Cited by 1,688
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
(1989) · PubMed · Cited by 1,639
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Taylor-Pashow, K. M. L., Della Rocca, J., Xie, Z., Tran, S., & Lin, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906198y · Cited by 1,522
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Direct Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391
Self-citationPapadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
The role of glutathione-S-transferase in anti-cancer drug resistance
Townsend, D. M., & Tew, K. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206940 · Cited by 1,353
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Fleige, E., Quadir, M. A., & Haag, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.020 · Cited by 1,111
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin
Kim, U.-J., Park, J., Joo Kim, H., Wada, M., & Kaplan, D. L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.044 · Cited by 979
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
(2006) · Structure and Bonding · doi:10.1007/b100426 · Cited by 962
Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility
O'Reilly, R. K., Hawker, C. J., & Wooley, K. L. (2006) · Chemical Society Reviews · doi:10.1039/b514858h · Cited by 939
Bisphosphonates: A review of their pharmacokinetic properties
Lin, J. H. (1996) · Bone · doi:10.1016/8756-3282(95)00445-9 · Cited by 932
Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide
Zhang, W., Guo, Z., Huang, D., Liu, Z., Guo, X., & Zhong, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.071 · Cited by 891
Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles
Karnik, R., Gu, F., Basto, P., Cannizzaro, C., Dean, L., Kyei-Manu, W., Langer, R., & Farokhzad, O. C. (2008) · Nano Letters · doi:10.1021/nl801736q · Cited by 887
He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885
On demonstrating DNA intercalation
Long, E. C., & Barton, J. K. (1990) · Accounts of Chemical Research · doi:10.1021/ar00177a001 · Cited by 876
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 843
Metal–organic frameworks as potential drug carriers
Huxford, R. C., Della Rocca, J., & Lin, W. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.12.012 · Cited by 840
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Alkilany, A. M., Thompson, L. B., Boulos, S. P., Sisco, P. N., & Murphy, C. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.005 · Cited by 807
Nanoscale Coordination Polymers for Platinum-Based Anticancer Drug Delivery
Rieter, W. J., Pott, K. M., Taylor, K. M. L., & Lin, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803383k · Cited by 803
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
Knight, W. A., Livingston, R. B., Gregory, E., & McGuire, W. L. (1977) · PubMed · Cited by 707
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Self-citationTargeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 673
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Wilson, J. J., & Lippard, S. J. (2014) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 630
Self-citationPlatinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & Travers, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 618
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Self-citationSpecific Recognition of Cruciform DNA by Nuclear Protein HMG1
Bianchi, M. E., Beltrame, M., & Paonessa, G. (1989) · Science · doi:10.1126/science.2922595 · Cited by 601
The role of DNA mismatch repair in platinum drug resistance.
Fink, D. A., Nebel, S., Aebi, S. P., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D., & Howell, S. B. (1996) · PubMed · Cited by 597
Carbon nanotubes for delivery of small molecule drugs
Wong, B. S., Yoong, S. L., Jagusiak, A., Panczyk, T., Ho, H. K., Ang, W. H., & Pastorin, G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.005 · Cited by 585
International Union of Pharmacology. LXIV. Estrogen Receptors
Dahlman-Wright, K., Cavailles, V., Fuqua, S. A., Jordan, V. C., Katzenellenbogen, J. A., Korach, K. S., Maggi, A., Muramatsu, M., Parker, M. G., & Gustafsson, J.-Å. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.8 · Cited by 583
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Self-citationShaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 550
Inhibition of transcription by platinum antitumor compounds
Todd, R. C., & Lippard, S. J. (2009) · Metallomics · doi:10.1039/b907567d · Cited by 539
Self-citationDai, Y., Xiao, H., Liu, J., Yuan, Q., Ma, P., Yang, D., Li, C., Cheng, Z., Hou, Z., Yang, P., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja410028q · Cited by 529
Biomedical applications of chemically-modified silk fibroin
Murphy, A. R., & Kaplan, D. L. (2009) · Journal of Materials Chemistry · doi:10.1039/b905802h · Cited by 521
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Self-citationDhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
Self-citationSpecific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Pil, P. M., & Lippard, S. J. (1992) · Science · doi:10.1126/science.1566071 · Cited by 496
Self-citationBancroft, D. P., Lepre, C. A., & Lippard, S. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00175a020 · Cited by 477
Self-citationCrystal structure of a bacterial homologue of glucose transporters GLUT1–4
Sun, L., Zeng, X., Yan, C., Sun, X., Gong, X., Rao, Y., & Yan, N. (2012) · Nature · doi:10.1038/nature11524 · Cited by 471
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Zheng, Y.-R., Suntharalingam, K., Johnstone, T. C., Yoo, H., Lin, W., Brooks, J. G., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5038269 · Cited by 440
Self-citationOrganic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Self-citationRosenberg, B., Van Camp, L., Grimley, E. B., & Thomson, A. J. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96186-7 · Cited by 420
DNA adducts : identification and biological significance
Hemminki, K. (1994) · Medical Entomology and Zoology · Cited by 406
Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9014032 · Cited by 400
(1993) · PubMed · Cited by 398
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Dhar, S., & Lippard, S. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912276106 · Cited by 369
Self-citationCisplatin Binding Sites on Human Albumin
Ivanov, A. I., Christodoulou, J., Parkinson, J. A., Barnham, K. J., Tucker, A., Woodrow, J., & Sadler, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14721 · Cited by 362
Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., & Johnson, J. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502011g · Cited by 362
Reflections on the Discovery and Significance of Estrogen Receptor β
Koehler, K. F., Helguero, L. A., Haldosén, L.-A., Warner, M., & Gustafsson, J.-A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0027 · Cited by 360
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
Ko, Y. H., Smith, B. L., Wang, Y., Pomper, M. G., Rini, D. A., Torbenson, M. S., Hullihen, J., & Pedersen, P. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.047 · Cited by 352
Recognition of cisplatin adducts by cellular proteins
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 349
Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347
Self-citationCopper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Howell, S. B., Safaei, R., Larson, C. A., & Sailor, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063172 · Cited by 344
Understanding and improving platinum anticancer drugs--phenanthriplatin.
Johnstone, T. C., Park, G. Y., & Lippard, S. J. (2014) · PubMed · Cited by 337
Self-citationPark, G. Y., Wilson, J. J., Song, Y., & Lippard, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207670109 · Cited by 330
Self-citationαVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Graf, N., Bielenberg, D. R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O. C., & Lippard, S. J. (2012) · ACS Nano · doi:10.1021/nn301148e · Cited by 327
Self-citationDesign of targeting ligands in medicinal inorganic chemistry
Storr, T., Thompson, K. H., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b514859f · Cited by 326
Ang, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
Min, Y., Li, J., Liu, F., Yeow, E. K. L., & Xing, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308834 · Cited by 309
Garin‐Chesa, P., Campbell, I., Saigo, P. E., Lewis, J. L., Old, L. J., & Rettig, W. J. (1993) · PubMed Central · Cited by 299
Metal Ions in Biological Systems: Volume 29: Biological Properties of Metal Alkyl Derivatives
Sigel, H., & Sigel, A. (2024) · CRC Press eBooks · doi:10.1201/9781003573890 · Cited by 288
Reduction and Anticancer Activity of Platinum(IV) Complexes
Choi, S., Filotto, C., Bisanzo, M., Delaney, S., Lagasee, D., Whitworth, J. L., Jusko, A., Li, C., Wood, N. A., Willingham, J., et al. (1998) · Inorganic Chemistry · doi:10.1021/ic971047x · Cited by 270
Encapsulation of Pt(iv) prodrugs within a Pt(ii) cage for drug delivery
Zheng, Y.-R., Suntharalingam, K., Johnstone, T. C., & Lippard, S. J. (2015) · Chemical Science · doi:10.1039/c4sc01892c · Cited by 265
Self-citationBarnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Self-citationPreclinical studies identifying carboplatin as a viable cisplatin alternative
Harrap, K. R. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90015-5 · Cited by 259
Lectins as pattern recognition molecules: The effects of epitope density in innate immunity
Dam, T. K., & Brewer, C. F. (2010) · Glycobiology · doi:10.1093/glycob/cwp186 · Cited by 257
The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin
Pathak, R. K., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308899 · Cited by 255
Liu, D., Poon, C., Lu, K., He, C., & Lin, W. (2014) · Nature Communications · doi:10.1038/ncomms5182 · Cited by 251
Graham, J., Muhsin, M., & Kirkpatrick, P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1287 · Cited by 251
Exploiting Sequence To Control the Hydrolysis Behavior of Biodegradable PLGA Copolymers
Li, J., Stayshich, R. M., & Meyer, T. Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200895s · Cited by 249
Detouring of cisplatin to access mitochondrial genome for overcoming resistance
Marrache, S., Pathak, R. K., & Dhar, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405244111 · Cited by 245
Photoactivatable Platinum Complexes
Bednarski, P. J., Mackay, F. S., & Sadler, P. J. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314053 · Cited by 244
Brabec, V, & Leng, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5345 · Cited by 240
Antitumor activity of 1,2-diaminocyclohexaneplatinum complexes against Sarcoma-180 ascites form
Kidani, Y., Inagaki, K., Iigo, M., Hoshi, A., & Kuretani, K. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00210a029 · Cited by 239
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
Self-citationTargeted delivery of platinum-based anticancer complexes
Butler, J. S., & Sadler, P. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.01.004 · Cited by 237
What pharmacologists can learn from recent advances in estrogen signalling
Gustafsson, J.-Å. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00229-3 · Cited by 236
Morohaku, K., Pelton, S. H., Daugherty, D. J., Butler, W. R., Deng, W., & Selvaraj, V. (2014) · Endocrinology · doi:10.1210/en.2013-1556 · Cited by 234
DNA Modifications by antitumor platinum and ruthenium compounds: Their recognition and repair
(2002) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(02)71040-4 · Cited by 230
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke, D. (1999) · PubMed · Cited by 227
Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
Mukhopadhyay, S., Barnés, C. M., Haskel, A., Short, S. M., Barnes, K. R., & Lippard, S. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc070031k · Cited by 226
Self-citationCarlsson, J., Nordgren, H., Sjöström, J., Wester, K., Villman, K., Bengtsson, N. O., Ostenstad, B., Lundqvist, H., & Blomqvist, C. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601881 · Cited by 225
Kèlland, L. R., Abel, G., McKeage, M. J., Jones, M., Goddard, P. M., Valenti, M., Murrer, B. A., & Harrap, K. R. (1993) · PubMed · Cited by 224
Lipoplatin Formulation Review Article
Stathopoulos, G. P., & Boulikas, T. (2012) · Journal of Drug Delivery · doi:10.1155/2012/581363 · Cited by 224
Monofunctional and Higher-Valent Platinum Anticancer Agents
Johnstone, T. C., Wilson, J. J., & Lippard, S. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400538c · Cited by 223
Self-citationCombating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201562 · Cited by 222
Error-prone translesion synthesis mediates acquired chemoresistance
Xie, K., Doles, J., Hemann, M. T., & Walker, G. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011412107 · Cited by 219
Pharmacology of bisphosphonates
Cremers, S., & Papapoulos, S. (2011) · Bone · doi:10.1016/j.bone.2011.01.014 · Cited by 217
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
Choy, H., Park, C., & Yao, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2176 · Cited by 217
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Platinum-Induced Filamentous Growth in Escherichia coli
Rosenberg, B., Renshaw, E., Vancamp, L., Hartwick, J., & Drobnik, J. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.2.716-721.1967 · Cited by 212
He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
Self-citationSpingler, B., Whittington, D. A., & Lippard, S. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010790t · Cited by 207
Self-citationSternberg, C. N., Whelan, P., Hetherington, J., Paluchowska, B., Slee, P. H. T. J., Vekemans, K., van Erps, P., Theodore, C., Koriakine, O., Oliver, T., et al. (2005) · Oncology · doi:10.1159/000084201 · Cited by 206
Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts
Hartman, J., Lindberg, K., Morani, A., Inzunza, J., Ström, A., & Gustafsson, J.-A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0017 · Cited by 206
Trans-Platinum Complexes in Cancer Therapy
Coluccia, M., & Natile, G. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007779314080 · Cited by 202
Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer.
Stetefeld, J., Kammerer, R. A., Jenny, M., Schulthess, T., Landwehr, R., & Engel, J. (2000) · Nature Structural Biology · doi:10.1038/79006 · Cited by 201
DNA polymerase zeta (pol ζ) in higher eukaryotes
Gan, G. N., Wittschieben, J. P., Wittschieben, B. Ø., & Wood, R. D. (2008) · Cell Research · doi:10.1038/cr.2007.117 · Cited by 201
Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.049 · Cited by 200
Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro Studies
Aronov, O., Horowitz, A. T., Gabizon, A., & Gibson, D. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025642l · Cited by 198
Casini, A., & Reedijk, J. (2012) · Chemical Science · doi:10.1039/c2sc20627g · Cited by 196
Bisphosphonates in cancer therapy
Stresing, V., Daubiné, F., Benzaid, I., Mönkkönen, H., & Clézardin, P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.007 · Cited by 196
Zhang, J. Z., Wexselblatt, E., Hambley, T. W., & Gibson, D. (2012) · Chem. Commun. · doi:10.1039/c1cc16647f · Cited by 190
Structure-Activity Relationships of Linear and Cyclic Peptides Containing the NGR Tumor-homing Motif
Colombo, G., Curnis, F., De Mori, G. M. S., Gasparri, A., Longoni, C., Sacchi, A., Longhi, R., & Corti, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207500200 · Cited by 188
Biodegradable polymer − cisplatin(IV) conjugate as a pro-drug of cisplatin(II)
Xiao, H., Qi, R., Liu, S., Hu, X., Duan, T., Zheng, Y., Huang, Y., & Jing, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.072 · Cited by 187
Bakalova, R., Ohba, H., Zhelev, Z., Nagase, T., Jose, R., Ishikawa, M., & Baba, Y. (2004) · Nano Letters · doi:10.1021/nl049627w · Cited by 187
Bellon, S. F., & Lippard, S. J. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80007-t · Cited by 186
Self-citationStructural and chemical aspects of HPMA copolymers as drug carriers☆
Ulbrich, K., & Šubr, V. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.007 · Cited by 186
Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
Wisnovsky, S. P., Wilson, J. J., Radford, R. J., Pereira, M. P., Chan, M. R., Laposa, R. R., Lippard, S. J., & Kelley, S. O. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.08.010 · Cited by 185
Self-citationCombating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie · doi:10.1002/ange.201201562 · Cited by 181
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Vyas, S. P., Singh, A., & Sihorkar, V. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i1.10 · Cited by 180
Stayshich, R. M., & Meyer, T. Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102670n · Cited by 178
A Third Mode of DNA Binding: Phosphate Clamps by a Polynuclear Platinum Complex
Komeda, S., Moulaei, T., Woods, K. K., Chikuma, M., Farrell, N. P., & Williams, L. D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062851y · Cited by 178
Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
Trifan, O. C., & Hla, T. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00222.x · Cited by 176
(1995) · PubMed · Cited by 173
Photoactivatable metal complexes: from theory to applications in biotechnology and medicine
Smith, N. A., & Sadler, P. J. (2013) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2012.0519 · Cited by 170
The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Cheng, Q., Shi, H., Wang, H., Min, Y., Wang, J., & Liu, Y. (2014) · Chem. Commun. · doi:10.1039/c4cc00419a · Cited by 170
Ueber die Einwirkung des Ammoniaks auf Platinchlorür
Peyrone, M. (1844) · Justus Liebigs Annalen der Chemie · doi:10.1002/jlac.18440510102 · Cited by 168
ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
Nowotnik, D. P., & Cvitkovic, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.004 · Cited by 167
Satraplatin: leading the new generation of oral platinum agents
Bhargava, A., & Vaishampayan, U. N. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903362437 · Cited by 167
Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Hartinger, C., Nazarov, A., Ashraf, S., Dyson, P., & Keppler, B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785908978 · Cited by 167
Yudasaka, M., Ajima, K., Suenaga, K., Ichihashi, T., Hashimoto, A., & Iijima, S. (2003) · Chemical Physics Letters · doi:10.1016/j.cplett.2003.08.095 · Cited by 164
Towards Antitumor Active trans‐Platinum Compounds
Aris, S. M., & Farrell, N. P. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200801118 · Cited by 160
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
Self-citationMi, Y., Zhao, J., & Feng, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.035 · Cited by 159
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
Barry, N. P. E., & Sadler, P. J. (2013) · ACS Nano · doi:10.1021/nn403220e · Cited by 148
Blommaert, F. A., van Dijk-Knijnenburg, H. C. M., Dijt, F. J., Engelse, L. D., Baan, R. A., Berends, F., & Fichtinger-Schepman, A. M. J. (1995) · Biochemistry · doi:10.1021/bi00026a031 · Cited by 145
Aydar, E., Palmer, C. P., & Djamgoz, M. B. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2329 · Cited by 144
Third row transition metals for the treatment of cancer
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2015) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2014.0185 · Cited by 143
Self-citationZhang, J., Bonnitcha, P., Wexselblatt, E., Klein, A. V., Najajreh, Y., Gibson, D., & Hambley, T. W. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201203159 · Cited by 142
Vaisman, A., Lim, S. E., Patrick, S. M., Copeland, W. C., Hinkle, D. C., Turchi, J. J., & Chaney, S. G. (1999) · Biochemistry · doi:10.1021/bi9909187 · Cited by 140
Safety of Poly(ethylene glycol) and Poly(ethylene glycol) Derivatives
Working, P. K., Newman, M. S., Johnson, J. A., & Cornacoff, J. B. (1997) · ACS symposium series · doi:10.1021/bk-1997-0680.ch004 · Cited by 139
Wang, D., Zhu, G., Huang, X., & Lippard, S. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002565107 · Cited by 133
Self-citationNedaplatin: a cisplatin derivative in cancer chemotherapy
Shimada, M., Kigawa, J., & Itamochi (2013) · Cancer Management and Research · doi:10.2147/cmar.s35785 · Cited by 133
Cheng, Z., Dai, Y., Kang, X., Li, C., Huang, S., Lian, H., Hou, Z., Ma, P., & Lin, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.029 · Cited by 132
Donahue, B. A., Augot, M., Bellon, S. F., Treiber, D. K., TONEY, J. H., Lippard, S. J., & Essigmann, J. M. (1990) · Biochemistry · doi:10.1021/bi00476a032 · Cited by 132
Self-citationHe, C., Liu, D., & Lin, W. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.017 · Cited by 131
Application of liposomal technologies for delivery of platinum analogs in oncology
Wang, A. Z., Lin, W., Liu, D., & He, C. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38354 · Cited by 130
Jodrell, D. I., Evans, T. R. J., Steward, W. P., Cameron, D., Prendiville, J., Aschele, C., Noberasco, C., Lind, M., Carmichael, J., Dobbs, N. A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.04.032 · Cited by 130
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kèlland, L. R., BARNARD, C. F. J., Mellish, K. J., Jones, M. A., Goddard, P. M., Valenti, M. R., Bryant, A., Murrer, B. A., & Harrap, K. R. (1994) · PubMed · Cited by 128
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Yang, J. J., Sun, X., Mao, W., Sui, M., Tang, J., & Shen, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200597r · Cited by 127
Polymeric drug delivery of platinum-based anticancer agents
Haxton, K. J., & Burt, H. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21611 · Cited by 125
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 125
Current status of the development of trans-platinum antitumor drugs
Perez, J. M. T., Fuertes, M. A., Alonso‐Moreno, C., & Navarro‐Ranninger, C. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00053-6 · Cited by 125
The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target
Galiègue, S., Tinel, N., & Casellas, P. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457223 · Cited by 125
Rerouting Chlorambucil to Mitochondria Combats Drug Deactivation and Resistance in Cancer Cells
Fonseca, S. B., Pereira, M. P., Mourtada, R., Gronda, M., Horton, K. L., Hurren, R., Minden, M. D., Schimmer, A. D., & Kelley, S. O. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.02.010 · Cited by 124
Li, J., Lyv, Z., Li, Y., Liu, H., Wang, J., Zhan, W., Chen, H., Chen, H., & Li, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.074 · Cited by 123
Yoong, S. L., Wong, B. S., Zhou, Q., Chin, C. F., Li, J., Venkatesan, T., Ho, H. K., Yu, V. C. K., Ang, W. H., & Pastorin, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.036 · Cited by 123
Farrell, N. (1996) · PubMed · Cited by 119
Pratesi, G., Perego, P., Polizzi, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 118
Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
Wilson, J. J., & Lippard, S. J. (2011) · Inorganic Chemistry · doi:10.1021/ic2000816 · Cited by 117
Self-citationPeters, J., Baumeister, W. P., & Lupas, A. N. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0221 · Cited by 116
Xiao, H., Li, W., Qi, R., Yan, L., Wang, R., Liu, S., Zheng, Y., Xie, Z., Huang, Y., & Jing, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.004 · Cited by 115
Liedert, B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl051 · Cited by 115
Farrell, N. P. (1993) · Cancer Investigation · doi:10.3109/07357909309011676 · Cited by 113
Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy
Suntharalingam, K., Song, Y., & Lippard, S. J. (2013) · Chemical Communications · doi:10.1039/c3cc48740g · Cited by 112
Self-citationBonetti, A. V., Leone, R., Muggia, F. M., & Howell, S. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-459-3 · Cited by 112
Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin
Qu, J., Liu, Y., Yu, Y., Li, J., Luo, J., & Li, M. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.08.034 · Cited by 111
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Neumann, W., Crews, B. C., Sárosi, M. B., Daniel, C. M., Ghebreselasie, K., Scholz, M., Marnett, L. J., & Hey‐Hawkins, E. (2014) · ChemMedChem · doi:10.1002/cmdc.201402353 · Cited by 111
Excursions in polynuclear platinum DNA binding
Mangrum, J. B., & Farrell, N. P. (2010) · Chemical Communications · doi:10.1039/c0cc01254h · Cited by 110
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Platinum-based drugs for cancer therapy and anti-tumor strategies
Zhang, C., Xu, C., Gao, X., & Yao, Q. (2022) · Theranostics · doi:10.7150/thno.69424 · Cited by 1,018
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Metadata
- Authors
- Johnstone, T. C., Suntharalingam, K., & Lippard, S. J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-11
- Volume
- 116
- Issue
- 5
- Pages
- 3436-3486
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2282989227
- Cited by
- 2,485
- References
- 332
- FWCI
- 32.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.